BANK VONTOBEL/CALL/ELI LILLY & CO/540/0.1/20.09.24 Share Price

Warrant

DE000VM3L3L0

Market Closed - Deutsche Boerse AG 11:25:40 28/06/2024 pm IST
35.49 EUR +1.89% Intraday chart for BANK VONTOBEL/CALL/ELI LILLY & CO/540/0.1/20.09.24
Current month+35.51%
1 month+41.73%
Date Price Change
28/24/28 35.49 +1.89%
27/24/27 34.83 +1.49%
26/24/26 34.32 -1.35%
25/24/25 34.79 +1.70%
24/24/24 34.21 +3.14%

Delayed Quote Deutsche Boerse AG

Last update June 28, 2024 at 11:25 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying ELI LILLY AND COMPANY
IssuerLogo Issuer Vontobel Vontobel
WKN VM3L3L
ISINDE000VM3L3L0
Date issued 06/10/2023
Strike 540 $
Maturity 20/09/2024 (83 Days)
Parity 10 : 1
Emission price 7.64
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 35.76
Lowest since issue 8.29
Delta0.97x
Omega 2.332
Premium1.04x
Gearing2.42x
Moneyness 1.677
Difference Strike -365.4 $
Difference Strike %-67.66%
Spread 0.02
Spread %0.06%
Intrinsic value 34.11

Company Profile

Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows: - endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems; - oncology (19.5%); - immunology diseases (11.1%); - neurology (8.4%): primarily drugs used in treating depression and schizophrenia; - other (3.3%). Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
More about the company

Ratings for Eli Lilly and Company

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Eli Lilly and Company

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
905.4 USD
Average target price
868.9 USD
Spread / Average Target
-4.03%
Consensus